Methylprednisolone sodium succinate NDC 70518-3684

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3684Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3684Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3684-0	70518368400	25 VIAL, SINGLE-DOSE in 1 CARTON (70518-3684-0) / 2 mL in 1 VIAL, SINGLE-DOSE (70518-3684-1)Marketed from Mar 17, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylprednisolone sodium succinate
Generic name (nonproprietary): methylprednisolone sodium succinate
Active ingredients: Methylprednisolone sodium succinate — 125 mg/2mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212396
Marketing start: Mar 17, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70518-3684_4f7f478b-3341-44cd-e063-6294a90a3ac3SPL ID 4f7f478b-3341-44cd-e063-6294a90a3ac3SPL set ID f339882f-c380-4022-bdcd-94556a7926aaRxCUI 1743704UNII LEC9GKY20K
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470518368400 followed by a unit qualifier and the quantity

Package 70518-3684-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE When oral therapy is not feasible, and the strength, dosage form and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of methylprednisolone sodium succinate for injection, USP is indicated as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases : Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema mult…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212396

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212396
Product	Strength	Form · route	Labeler	Product NDC
Methylprednisolone Sodium Succinatemethylprednisolone	Methylprednisolone sodium succinate 500 mg/8mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Tianjin Kingyork Pharmaceuticals Co., Ltd	82094-403
Methylprednisolone Sodium Succinatemethylprednisolone	Methylprednisolone sodium succinate 40 mg/mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Tianjin Kingyork Pharmaceuticals Co., Ltd	82094-401
Methylprednisolone Sodium Succinatemethylprednisolone	Methylprednisolone sodium succinate 125 mg/2mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Tianjin Kingyork Pharmaceuticals Co., Ltd	82094-402
Methylprednisolone Sodium Succinatemethylprednisolone	Methylprednisolone sodium succinate 1 g/16mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Tianjin Kingyork Pharmaceuticals Co., Ltd	82094-404
Methylprednisolone Sodium Succinatemethylprednisolone	Methylprednisolone sodium succinate 2 g/30.6mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Tianjin Kingyork Pharmaceuticals Co., Ltd	82094-405
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 40 mg/mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-127
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 1 g/16mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-130
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 500 mg/8mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-128
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 125 mg/2mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-129
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 125 mg/2mL	InjectionIntravascular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1695